glp 1 agonist drug list Comparing Ozempic, Wegovy and Other GLP-1 Drugs GLP-1 Receptor Agonists | New
Description
While short-acting versions like daily injections may better control postprandial glucose levels, they have largely been replaced by long-acting alternatives such as semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound), which only require weekly injections

Lancet 398 (10295), 143155
Where this is genuinely useful to know now: if youre the type of patient who likes to understand whats coming before deciding when to treat, Sculpt is one to keep an eye on through 2026 and into 2027
Accordingly, the bulk of the clinical evidence of the effects of the drug class on HF have been collected in the placebo-controlled CVOTs in people with type 2 diabetes and established CVD or CVD risk (Table 1) (Pfeffer et al., 2015

Consistent with this, adenoviral overexpression of PCSK1 in -cells increases islet GLP-1 production and secretion, ultimately leading to enhanced glucose-stimulation of insulin secretion and improved survival of the islets [165]

This focus aligns with the increase in utilization and pharmacy spend on these conditions
